Bulletin of Semashko National Research Institute of Public HealthBulletin of Semashko National Research Institute of Public Health2415-84102415-8429FSSBI «N.A. Semashko National Research Institute of Public Health»1686Научная статьяEVOLUTION AND PREVENTION OF CARDIOVASCULAR DISEASESGrosuV. Vvictoria.grosu@usmf.md151220171475014042022Copyright © 2017,2017Cardiovascular morbidity and mortality are analysed. Influence mechanisms of their risk factors and most effective correction methods are discussed.atherosclerosisischemic heart diseasearterial hypertensionатеросклерозишемическая болезнь сердцаартериальная гипертензия1.Кобалава Ж.Д. с соавт. Мочевая кислота - маркер и/или новый фактор риска развития сердечно-сосудистых осложнений // Клин фармакология и терапия. - 2002. - № 11. - С. 32-39.2.ACE Position Statement on the Insulin Resistance Syndrome // Endocrin Pract. - 2003. - V. 9. № 3. - Р. 240-252.3.ESH-ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) // Eur Heart J. - 2013. - № 34. - Р. 2159-2219.4.Fracchini E. et al. Relationship between resistance to insulin-mediated glucose uptake, urinary acid clearance, and plasma uric acid concentration // JAMA. - 1991. - № 266. - Р. 3008-3011.5.Mensah G.A. et al. Obezity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implication // Cardiol Clin. -2004. - № 22. - Р. 485-504.6.World Health Report 2005: Reducing risks, promoting healthy life. -http://www.who.int/whr/2005.